Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.41 (market cap $6.04B), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.46 (market cap $127.85B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 21.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.72% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days on average.
| IOVA | MFG | |
|---|---|---|
Market Cap | $6.04B | $127.85B |
Volume | 14,805,993 | 3,950,750 |
Sector | Health | Financials |
52-Week High | $14.82 | $11.45 |
52-Week Low | $1.81 | $6.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $35.14T |
Dividend Yield | — | 1.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Mizuho Financial Group Inc. Sponosred ADR (Japan)
Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →
